"AOP Health commitment doesn't end at the company door. We live it - no matter where we are and when we are needed."
Personal Data Sheet
Georg Fischer is a medical doctor and holds an additional qualification in pharmacology from the Austrian Medical Association. During his extensive career he did basic research, served as hospital doctor before taking on numerous functions in the pharmaceutical industry which included clinical research, medical affairs, marketing & selling as well as business development. Dr Fischer gained profound experience in the pharmaceutical industry at Eli Lilly, Wyeth-Lederle Pharma and AOP Health. He joined the Board of the AOP Health in 2020 and was appointed as a CEO of AOP Orphan Pharmaceuticals GmbH in July 2021.